BioPharma Dive15h
PTC wins US approval of gene therapy for fatal enzyme disorder
Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...
Bluebird bio says it needs cash to operate beyond March 2025
Bluebird bio Inc., which nine years ago was worth nearly as much as the airline JetBlue, said it's now looking for enough ...
Altering two genes to produce sweeter tomatoes without sacrificing size, weight or yield
A team of horticulturists, bio-breeders and agriculture specialists affiliated with a host of institutions across China has ...
ENDPOINTS NEWS21h
As blue­bird projects more com­mer­cial de­mand, the biotech con­tin­ues to seek cash
Bluebird reports 17 people with sickle cell disease started receiving Lyfgenia gene therapy, with 35 starting Zynteglo for ...
BioSpace23h
PTC Wins First FDA Nod for Direct-to-Brain Gene Therapy, Targets Ultrarare Disease
The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene ...